Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01776827 · ClinicalTrials.gov registry record
Long-term Outcome of Laparoscopic Hiatal Hernia Repair With or Without Alloderm Mesh at a University Hospital
A clinical trial of Gastroesophageal Reflux Disease and Hiatal Hernia, sponsored by University of Nebraska.
- Completed
- Registry status
- 69
- Enrollment target
- 1
- Study location
NCT01776827: Completed study of Gastroesophageal Reflux Disease and Hiatal Hernia, sponsored by University of Nebraska.
NCT01776827 is a study of Gastroesophageal Reflux Disease and Hiatal Hernia that has completed, run by University of Nebraska. The registered enrollment target is 69 participants, below the 353-participant average among 25 other Gastroesophageal Reflux Disease trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01776827, a study of Gastroesophageal Reflux Disease and Hiatal Hernia, has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- 69 participants
- Enrollment target
- 1
- Study location
Study Summary
To study the long term outcome of Laparoscopic Hiatal Hernia Repair with human acellular dermal matrix Alloderm (LifeCell, Branchburg, NJ) mesh.
Primary Outcome
Patients will be questioned concerning their gastroesophageal reflux symptoms and hernia recurrence will be assessed using a barium swallow and x-rays.
Conditions Studied
Study Locations (1)
Nebraska
- University of Nebraska Medical Center - Omaha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2012-05-22 |
| Est. Completion | 2015-02-11 |
What the finished NCT01776827 record still lists
NCT01776827 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 69 participants, a relatively small participant target, below the 353-participant average among 25 other Gastroesophageal Reflux Disease trials with a reported enrollment target (80% lower).
The record links to 3 conditions, with Gastroesophageal Reflux Disease appearing as the primary indexed condition, and to 0 interventions.
NCT01776827 reports a single indexed study location in Nebraska.
Frequently Asked Questions
What is clinical trial NCT01776827 about?
NCT01776827 is a clinical study titled "Long-term Outcome of Laparoscopic Hiatal Hernia Repair With or Without Alloderm Mesh at a University Hospital". To study the long term outcome of Laparoscopic Hiatal Hernia Repair with human acellular dermal matrix Alloderm (LifeCell, Branchburg, NJ) mesh.
What is the current status of trial NCT01776827?
This trial is currently completed. The enrollment target is 69 participants. The study started on 2012-05-22. Estimated completion is 2015-02-11.
What conditions does trial NCT01776827 study?
This clinical trial studies the following conditions: Gastroesophageal Reflux Disease, Hiatal Hernia, Paraesophageal Hernia.
Who is sponsoring clinical trial NCT01776827?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01776827 being conducted?
This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastroesophageal Reflux Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01776827's enrollment target sits among peer trials
69 15th of 25 higher than 11 of 25 other Gastroesophageal Reflux Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gastroesophageal Reflux Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
Progression of Gastroesophageal Reflux Disease and Barrett's Esophagus and the Creation of a Barrett's Registry
RECRUITING
-
Domperidone in Treating Patients With Gastrointestinal Disorders
RECRUITING · Phase 3
-
Patient Preferences for Barrett's Esophagus and Esophageal Cancer Screening Tests
RECRUITING
-
Outcomes After Medical and Surgical Treatment of Gastroesophageal Reflux Disease
ACTIVE NOT RECRUITING
-
GCC Agonist Signal in the Small Intestine
ACTIVE NOT RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04020575 · 69 participants · Phase 1
Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)
- NCT04163614 · 69 participants · NA
Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients
- NCT04164641 · 69 participants · NA
Noraxon myoRESEARCH™ Software Gait Analysis Evaluation and Orthotic Gait Correction in Reducing Diabetic Foot Ulceration Or Subsequent Amputation in Patients With a History of a Diabetic Foot Ulceration
- NCT04493372 · 69 participants · NA
Deciphering Preserved Autonomic Function After Spinal Cord Injury
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI